http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2006040660-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_aea04754d5f2ad8bae6d679e185e62bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_272beef7217297ecd90e241fe41a76c9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_573359014702690994a57ff8de21d7c2
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_709c3210de67858b7124cdb2cc0ec1a7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4250cf62248ff868d1d1189580d86c7
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-71
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-64
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-001106
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-09
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-005
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-71
filingDate 2005-10-13-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f335e5689581e8328d22745ca7913e8f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d41d2ba35ea0b2019fc31925c5a0579
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_39fa89d48c08012912c09737da15ad96
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_af93b2dc7471c890da3e08a09b7a5475
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_442475ce0bc5f30c30ef5a0c3f3a0eda
publicationDate 2006-04-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2006040660-A2
titleOfInvention Plasmids coding for p185neu protein sequence variants and therapeutic uses thereof
abstract DNA plasmids containing sequences coding for different fragments of 185neu oncoprotein which are able to induce an immune response against p185neu-overexpressing tumors, and pharmaceutical compositions thereof are described.
priorityDate 2004-10-15-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005039618-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0044899-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004041065-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005129715-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2002177551-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6249
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID520348
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226395685
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415987357

Total number of triples: 36.